牛津新冠疫苗的免疫检测结果。
Immune readouts from the Oxford COVID-19 vaccine.
作者信息
Bordon Yvonne
机构信息
Nature Reviews Immunology, .
出版信息
Nat Rev Immunol. 2021 Feb;21(2):70-71. doi: 10.1038/s41577-021-00503-4.
Abstract
Two studies from the Oxford COVID-19 vaccine team describe the immune responses that develop in healthy adults following a single dose or two doses of their adenovirus vector-based COVID-19 vaccine.
摘要
牛津大学新冠疫苗团队的两项研究描述了健康成年人在接种一剂或两剂其基于腺病毒载体的新冠疫苗后产生的免疫反应。
相似文献
1
Immune readouts from the Oxford COVID-19 vaccine.牛津新冠疫苗的免疫检测结果。
Nat Rev Immunol. 2021 Feb;21(2):70-71. doi: 10.1038/s41577-021-00503-4.
2
Sustained COVID-19 vaccine willingness after safety concerns over the Oxford-AstraZeneca vaccine.对牛津-阿斯利康疫苗的安全性担忧后，对 COVID-19 疫苗的持续意愿。
Dan Med J. 2021 Mar 31;68(5):A03210292.
3
Oxford COVID-19 Vaccine Hesitancy in School Principals: Impacts of Gender, Well-Being, and Coronavirus-Related Health Literacy.牛津大学关于学校校长对新冠疫苗接种的犹豫态度：性别、幸福感和冠状病毒相关健康素养的影响
Vaccines (Basel). 2021 Sep 3;9(9):985. doi: 10.3390/vaccines9090985.
4
Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database.关于Moderna、辉瑞和牛津-阿斯利康新冠疫苗报告的血栓形成不良事件：欧洲药物警戒数据库中发生率和临床结果的比较
Vaccines (Basel). 2021 Nov 15;9(11):1326. doi: 10.3390/vaccines9111326.
5
Minimal Change Disease With Severe Acute Kidney Injury Following the Oxford-AstraZeneca COVID-19 Vaccine: A Case Report.牛津-阿斯利康新冠疫苗接种后发生伴有严重急性肾损伤的微小病变肾病：一例报告
Am J Kidney Dis. 2021 Oct;78(4):607-610. doi: 10.1053/j.ajkd.2021.06.008. Epub 2021 Jul 7.
6
Trainee and Attending Perspectives on Remote Radiology Readouts in the Era of the COVID-19 Pandemic.新冠疫情时代下实习医生和主治医生对远程放射学读片的看法。
Acad Radiol. 2020 Aug;27(8):1147-1153. doi: 10.1016/j.acra.2020.05.019. Epub 2020 May 23.
7
Prospective Evaluation of Side-Effects Following the First Dose of Oxford/AstraZeneca COVID-19 Vaccine among Healthcare Workers in Saudi Arabia.沙特阿拉伯医护人员接种第一剂牛津/阿斯利康新冠疫苗后副作用的前瞻性评估
Vaccines (Basel). 2022 Jan 30;10(2):223. doi: 10.3390/vaccines10020223.
8
A Single Dose of SARS-CoV-2 Vaccine Primes a Strong Humoral Immune Response in COVID-19-Recovered Patients.一剂 SARS-CoV-2 疫苗可在 COVID-19 康复患者中引发强烈的体液免疫应答。
Viral Immunol. 2022 Mar;35(2):122-128. doi: 10.1089/vim.2021.0108. Epub 2021 Nov 5.
9
BioNTech/Pfizer vaccine after Oxford/AZ vaccine increased immune response vs. no second vaccine.辉瑞/生物科技疫苗接种后，与不接种第二剂疫苗相比，免疫反应增强。
Ann Intern Med. 2021 Nov;174(11):JC123. doi: 10.7326/ACPJ202111160-123. Epub 2021 Nov 2.
10
Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine.接种ChAdOx1 nCoV-19（牛津-阿斯利康）疫苗后发生的自身免疫性肝炎。
J Hepatol. 2021 Nov;75(5):1249-1250. doi: 10.1016/j.jhep.2021.06.014. Epub 2021 Jun 22.
引用本文的文献
1
The mechanisms of immune response and evasion by the main SARS-CoV-2 variants.主要SARS-CoV-2变体的免疫反应及逃逸机制。
iScience. 2022 Oct 21;25(10):105044. doi: 10.1016/j.isci.2022.105044. Epub 2022 Sep 2.
2
Adult-onset nephrotic syndrome following coronavirus disease vaccination.冠状病毒病疫苗接种后出现的成人肾病综合征
Clin Kidney J. 2021 Aug 28;15(1):168-170. doi: 10.1093/ckj/sfab153. eCollection 2022 Jan.
3
Putative Role of Vitamin D for COVID-19 Vaccination.维生素 D 对 COVID-19 疫苗接种的推测作用。
Int J Mol Sci. 2021 Aug 20;22(16):8988. doi: 10.3390/ijms22168988.
本文引用的文献
1
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.在一项 1/2 期临床试验中，单次接种 ChAdOx1 nCoV-19（AZD1222）疫苗诱导的 T 细胞和抗体反应。
Nat Med. 2021 Feb;27(2):270-278. doi: 10.1038/s41591-020-01194-5. Epub 2020 Dec 17.
Zotero 插件